| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| Gene symbol | TGFB1 | Synonyms | CED, DPD1, IBDIMDE, LAP, TGF-beta1, TGFB, TGFbeta | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | transforming growth factor beta 1 | ||||
| GTO ID | GTC1751 |
| Trial ID | NCT03198546 |
| Disease | Hepatocellular Carcinoma | Lung Squamous Cell Carcinoma |
| Altered gene | GPC3|TGFB1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3/TGFβ CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression |
| Year | 2017 |
| Country | China |
| Company sponsor | Second Affiliated Hospital of Guangzhou Medical University |
| Other ID(s) | ZZCART-003 |
| Cohort 1 | |||||||||||
|
|||||||||||